1-14 of 14
Elisabeth Kueenburg
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Clinical Assessment of Mocravimod As a Victim of Drug-Drug Interactions Via CYP3A Metabolism and Transporters

Dymphy Huntjens, Stephan Oehen, Elisabeth Kueenburg
Journal: Blood
Blood (2024) 144 (Supplement 1): 5774.
https://doi.org/10.1182/blood-2024-193899
Published: 2024
Journal Articles

MO-TRANS: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Phase III Study of Mocravimod (MOC) As Adjunctive and Maintenance Treatment in AML Patients Undergoing Allogeneic Hematopoietic Cell Transplantation

Gabriela Sanchez-Petitto, Maria Calbacho, Agata Wieczorkiewicz-Kabut, Malika Souquieres, Julien Cachat, Imene Henaoui, Daniel Ghali, Cristina Fernandez, Jeff Steinberg, Stephan Oehen, Christos Stylianou, Elisabeth Kueenburg, Marcos de Lima
Journal: Blood
Blood (2024) 144 (Supplement 1): 4952.1.
https://doi.org/10.1182/blood-2024-203080
Published: 2024
Journal Articles

MO-TRANS: A Phase 2b Placebo-Controlled Study of Mocravimod As Adjunctive and Maintenance Treatment in AML Patients Undergoing Allogeneic Hematopoietic Cell Transplant

Marcos de Lima, Florent Malard, Eduardo Olavarria, Estefanía Pérez López, Michael Medinger, Elisabeth Kueenburg, Malika Souquieres, Julien Cachat, Christos Stylianou, Patrice Chevallier
Journal: Blood
Blood (2022) 140 (Supplement 1): 12936–12937.
https://doi.org/10.1182/blood-2022-159785
Published: 2022
Journal Articles

Iberdomide (IBER) in Combination with Dexamethasone (DEX) in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM): Results from the Dose-Expansion Phase of the CC-220-MM-001 Trial

Sagar Lonial, Rakesh Popat, Cyrille Hulin, Sundar Jagannath, Albert Oriol, Paul G. Richardson, Thierry Facon, Katja Weisel, Jeremy T. Larsen, Monique C. Minnema, Al-Ola Abdallah, Ashraf Z. Badros, Stefan Knop, Edward A. Stadtmauer, Min Chen, Tuong Vi Nguyen, Alpesh Amin, Elisabeth Kueenburg, Teresa Peluso, Niels W.C.J. van de Donk
Journal: Blood
Blood (2021) 138 (Supplement 1): 162.
https://doi.org/10.1182/blood-2021-147704
Published: 2021
Journal Articles

First Results of Iberdomide (IBER; CC-220) in Combination with Dexamethasone (DEX) and Daratumumab (DARA) or Bortezomib (BORT) in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)

Niels W.C.J. van de Donk, MD PhD, Rakesh Popat, Jeremy Larsen, Monique C. Minnema, Sundar Jagannath, MD, Albert Oriol, Jeffrey Zonder, Paul G. Richardson, MD, Paula Rodriguez-Otero, MD PhD, Ashraf Z. Badros, MD, Edward Stadtmauer, Sara Bringhen, MD, Erica Campagnaro, MD, David S. Siegel, MD PhD, Barbara Gamberi, Mercedes Gironella Mesa, Pieter Sonneveld, MD PhD, Tuong Vi Nguyen, Antonia Di Micco, April Sorrell, Min Chen, Michael Amatangelo, Elisabeth Kueenburg, Sagar Lonial, MD FACP
Journal: Blood
Blood (2020) 136 (Supplement 1): 16–17.
https://doi.org/10.1182/blood-2020-137743
Published: 2020
Journal Articles

Safety Profile for Lenalidomide-Based and Non-Lenalidomide-Based First-Line Therapy for Multiple Myeloma in Transplant Ineligible Patients: Real-World Evidence from a European Post-Authorization Safety Study

Michele Cavo, Valerio De Stefano, MD, Angel Ramirez Payer, Martin Wiesholzer, Yvonne Tromp, Gaëtan Vanstraelen, Baerbel Schaedlich, Richez Valentine, Sujith Dhanasiri, Elisabeth Kueenburg, Barbara Rosettani, Claire Martin, Stefano Pozzi, Pamela Bacon, Barbara Gamberi
Journal: Blood
Blood (2019) 134 (Supplement_1): 5580.
https://doi.org/10.1182/blood-2019-124555
Published: 2019
Journal Articles

Safety in Patients with Multiple Myeloma Treated with Pomalidomide in a Real-World Setting According to Last Prior Treatment: A European Post-Authorization Safety Study

Niels Abildgaard, MD PhD, Marie-Christiane Vekemans, Barbara Gamberi, MD, Francesco Di Raimondo, MD, Angel Ramirez Payer, Charalampia Kyriakou, Alain Kentos, Elisabeth Kueenburg, Antonia Di Micco, Barbara Rosettani, Pamela Bacon, Margaret Atiba-Davies, Torben Plesner, MD DSc
Journal: Blood
Blood (2018) 132 (Supplement 1): 3286.
https://doi.org/10.1182/blood-2018-99-111906
Published: 2018
Journal Articles

MM-013 Phase 2, Multicenter Study of Pomalidomide (POM) Plus Low-Dose Dexamethasone (LoDEX) in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM) and Renal Impairment (RI): Pharmacokinetics (PK) Analysis

Pieter Sonneveld, MDPhD, Katja C. Weisel, Yan Li, Elisabeth Kueenburg, Shona Collins, Antonia Di Micco, Barbara Rosettani, Pamela Bacon, Meletios A. Dimopoulos
Journal: Blood
Blood (2017) 130 (Supplement 1): 1847.
https://doi.org/10.1182/blood.V130.Suppl_1.1847.1847
Published: 2017
Journal Articles

European Post-Approval Safety Study (Registry) of Relapsed/Refractory Multiple Myeloma (RRMM): Safety of Patients Treated with Pomalidomide

Francesco Di Raimondo, Charalampia Kyriakou, Martin Schmidt-Hieber, Marie-Christiane Vekemans, Ángel Ramírez Payer, Pal Tore Bentsen, Birgitta Lauri, Elisabeth Kueenburg, Frederik Lersch, Barbara Rosettani, Pamela Bacon, Torben Plesner, Professor
Journal: Blood
Blood (2016) 128 (22): 5680.
https://doi.org/10.1182/blood.V128.22.5680.5680
Published: 2016
Journal Articles

European Post-Approval Safety Study (PASS) of Relapsed/Refractory Multiple Myeloma (RRMM): Safety, Including SPM, in a Large Cohort of Patients Treated with Lenalidomide, Thalidomide, and Bortezomib

Barbara Gamberi, Miguel Hernandez, Christian Berthou, Eleni Tholouli, Elena Zamagni, Roman Hájek, Monique Minnema, Meletios A Dimopoulos, Jo Caers, Niels Frost Andersen, Bjorn Andreasson, Anders Waage, MD PhD, Gerard Crotty, Elisabeth Kueenburg, Barbara Rosettani, Antonia Di Micco, Pamela Bacon, Igor Blau
Journal: Blood
Blood (2016) 128 (22): 3331.
https://doi.org/10.1182/blood.V128.22.3331.3331
Published: 2016
Journal Articles

Safety Results of a Phase 2 Multicenter, Open-Label Study of Pomalidomide (CC-4047) Plus Low-Dose Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma (RRMM) and Renal Impairment

Katja Weisel, MD, Meletios A Dimopoulos, Niels W.C.J. van de Donk, MD PhD, Karthik Ramasamy, Barbara Gamberi, Matthew Streetly, Massimo Offidani, Frank Bridoux, Javier de la Rubia, Elisabeth Kueenburg, Frederik Lersch, Barbara Rosettani, Pamela Bacon, Pieter Sonneveld
Journal: Blood
Blood (2016) 128 (22): 3311.
https://doi.org/10.1182/blood.V128.22.3311.3311
Published: 2016
Journal Articles

Safety of Treatment (Tx) with Pomalidomide (POM) and Low-Dose Dexamethasone (LoDEX) in Patients (Pts) with Relapsed or Refractory Multiple Myeloma (RRMM) and Renal Impairment (RI), Including Those on Dialysis

Karthik Ramasamy, Meletios A. Dimopoulos, Niels W.C.J. van de Donk, Barbara Gamberi, Frank Bridoux, Matthew Streetly, Elisabeth Kueenburg, Barbara Rosettani, Shona Collins, Frederik Lersch, Pamela Bacon, Katja C. Weisel, Pieter Sonneveld, MD PhD
Journal: Blood
Blood (2015) 126 (23): 374.
https://doi.org/10.1182/blood.V126.23.374.374
Published: 2015
Journal Articles

Post-Approval Safety Study (PASS) of Lenalidomide Compared with Other Treatments in Patients with Relapsed or Refractory Multiple Myeloma

Michele Cavo, MD, Luciano Masini, Igor W. Blau, Miguel T. Hernandez, Renato Zambello, Paolo de Fabritiis, Christian Berthou, Argiris Symeonidis, Jennifer Bird, Javier De La Rubia, Pamela Bacon, Barbara Rosettani, Elisabeth Kueenburg, Neil Minton
Journal: Blood
Blood (2011) 118 (21): 1867.
https://doi.org/10.1182/blood.V118.21.1867.1867
Published: 2011
Journal Articles

OPTIMUM Dose of Thalidomide for Relapsed Multiple Myeloma.

Martin Kropff, Honorata Giongco Baylon, MD, Jens Hillengass, MD, Tadeusz Robak, Roman Hajek, MD, Peter Liebisch, MD, Stefan Goranov, MD, Cyrille Hulin, Joan Blade, Tomaso Caravita, Herve Avet-Loiseau, MD, PhD, Thomas M. Moehler, Claire Pattou, Lela Lucy, Elisabeth Kueenburg, Axel Glasmacher, MD, Robert Zerbib, Thierry Facon
Journal: Blood
Blood (2009) 114 (22): 959.
https://doi.org/10.1182/blood.V114.22.959.959
Published: 2009